Final analysis results from TITAN: A phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).


Chi K. N. , Chowdhury S., Bjartell A., Chung B. H. , de Santana Gomes A. J. P. , Given R., ...More

JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.6, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 39 Issue: 6
  • Publication Date: 2021
  • Doi Number: 10.1200/jco.2021.39.6_suppl.11
  • Title of Journal : JOURNAL OF CLINICAL ONCOLOGY